Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration

. 2015 Jun ; 39 (6) : 986-93. [epub] 20150316

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25771926

OBJECTIVES: Obesity is a frequent metabolic disorder but an effective therapy is still scarce. Anorexigenic neuropeptides produced and acting in the brain have the potential to decrease food intake and ameliorate obesity but are ineffective after peripheral application. We have designed lipidized analogs of prolactin-releasing peptide (PrRP), which is involved in energy balance regulation as demonstrated by obesity phenotypes of both PrRP- and PrRP-receptor-knockout mice. RESULTS: Lipidized PrRP analogs showed binding affinity and signaling in PrRP receptor-expressing cells similar to natural PrRP. Moreover, these analogs showed high binding affinity also to anorexigenic neuropeptide FF-2 receptor. Peripheral administration of myristoylated and palmitoylated PrRP analogs to fasted mice induced strong and long-lasting anorexigenic effects and neuronal activation in the brain areas involved in food intake regulation. Two-week-long subcutaneous administration of palmitoylated PrRP31 and myristoylated PrRP20 lowered food intake, body weight and improved metabolic parameters, and attenuated lipogenesis in mice with diet-induced obesity. CONCLUSIONS: Our data suggest that the lipidization of PrRP enhances stability and mediates its effect in central nervous system. Strong anorexigenic and body-weight-reducing effects make lipidized PrRP an attractive candidate for anti-obesity treatment.

Zobrazit více v PubMed

Brain Res. 2004 Jul 16;1014(1-2):61-70 PubMed

Nature. 1998 May 21;393(6682):272-6 PubMed

Pharm Res. 2004 Aug;21(8):1498-504 PubMed

Neurochem Int. 2011 Nov;59(6):889-95 PubMed

Peptides. 2007 Oct;28(10):1945-53 PubMed

Endocrinology. 2002 Feb;143(2):360-7 PubMed

Trends Pharmacol Sci. 2010 Sep;31(9):434-41 PubMed

Physiol Behav. 2013 Sep 10;121:35-42 PubMed

Curr Protoc Neurosci. 2002 Aug;Chapter 7:Unit 7.5 PubMed

Brain Res. 2013 Mar 1;1498:33-40 PubMed

Biochem Biophys Res Commun. 2007 Nov 23;363(3):633-8 PubMed

Neuroendocrinology. 2000 Apr;71(4):262-7 PubMed

Endocrinology. 2006 Jul;147(7):3190-5 PubMed

Peptides. 2011 Sep;32(9):1887-92 PubMed

Physiol Res. 2013;62(4):435-44 PubMed

Clin Sci (Lond). 2011 Aug;121(3):107-17 PubMed

Neurosci Res. 2000 Nov;38(3):223-30 PubMed

Endocrinology. 2006 Oct;147(10):4723-9 PubMed

Mol Cell Endocrinol. 2011 Aug 22;343 (1-2):55-62 PubMed

Neuropeptides. 2011 Oct;45(5):309-16 PubMed

Peptides. 2011 Apr;32(4):811-7 PubMed

Peptides. 2006 May;27(5):1110-20 PubMed

Prog Neurobiol. 2009 Apr;87(4):212-51 PubMed

Diabetes Obes Metab. 2010 Oct;12(10):891-9 PubMed

Front Endocrinol (Lausanne). 2013 Mar 05;4:20 PubMed

Exp Physiol. 2004 May;89(3):229-35 PubMed

Biochem Pharmacol. 2010 Aug 1;80(3):396-401 PubMed

J Pharmacol Exp Ther. 2012 Mar;340(3):781-6 PubMed

Am J Physiol. 1996 May;270(5 Pt 1):E768-75 PubMed

Nat Neurosci. 2000 Jul;3(7):645-6 PubMed

Brain Res. 2014 Feb 14;1547:16-24 PubMed

Biochem Pharmacol. 1978;27(19):2297-300 PubMed

Eur J Pharmacol. 1992 Nov 10;222(2-3):233-40 PubMed

BMC Neurosci. 2008 Oct 21;9:101 PubMed

Endocrinology. 1999 Dec;140(12):5736-45 PubMed

J Pharmacol Exp Ther. 2003 Jun;305(3):825-32 PubMed

Peptides. 2013 Jan;39:138-44 PubMed

J Clin Invest. 2008 Dec;118(12):4014-24 PubMed

Endocrinology. 2001 May;142(5):2032-8 PubMed

Ther Adv Chronic Dis. 2014 May;5(3):135-48 PubMed

J Pept Sci. 2005 Mar;11(3):161-5 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Deficiency of GPR10 and NPFFR2 receptors leads to sex-specific prediabetic syndrome and late-onset obesity in mice

. 2024 Oct 30 ; 44 (10) : .

Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides

. 2024 Apr 24 ; 44 (4) : .

An analogue of the Prolactin Releasing Peptide reduces obesity and promotes adult neurogenesis

. 2024 Jan ; 25 (1) : 351-377. [epub] 20231220

Lipidization as a tool toward peptide therapeutics

. 2023 Dec ; 30 (1) : 2284685. [epub] 20231127

High-Fat Diet Induces Resistance to Ghrelin and LEAP2 Peptide Analogs in Mice

. 2023 Nov 28 ; 72 (5) : 607-619.

Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice

. 2023 Aug 23 ; 15 (17) : . [epub] 20230823

NPFFR2-deficient mice fed a high-fat diet develop strong intolerance to glucose

. 2023 May 31 ; 137 (10) : 847-862.

Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance

. 2023 Jan 05 ; 15 (2) : . [epub] 20230105

Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances

. 2022 May 19 ; 12 (1) : 26. [epub] 20220519

Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models

. 2021 ; 12 () : 779962. [epub] 20211118

Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice

. 2021 Aug 31 ; 70 (4) : 579-590. [epub] 20210601

Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study

. 2021 Aug 18 ; 22 (16) : . [epub] 20210818

Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22

. 2021 Jun 22 ; 18 (1) : 141. [epub] 20210622

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides

. 2020 ; 11 () : 597583. [epub] 20201126

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells

. 2020 Sep 01 ; 21 (17) : . [epub] 20200901

Prolactin-Releasing Peptide: Physiological and Pharmacological Properties

. 2019 Oct 24 ; 20 (21) : . [epub] 20191024

Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study

. 2018 Jan 16 ; 8 (1) : 5. [epub] 20180116

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity

. 2017 ; 12 (8) : e0183449. [epub] 20170818

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...